ASB Consultores LLC lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 34.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,442 shares of the exchange traded fund’s stock after selling 8,767 shares during the period. SPDR S&P Biotech ETF accounts for about 0.5% of ASB Consultores LLC’s holdings, making the stock its 22nd biggest position. ASB Consultores LLC’s holdings in SPDR S&P Biotech ETF were worth $1,524,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of XBI. ICA Group Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $27,000. Scarborough Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $32,000. BOCHK Asset Management Ltd purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $36,000. ORG Partners LLC bought a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $40,000. Finally, Vima LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $45,000.
SPDR S&P Biotech ETF Price Performance
XBI stock opened at $102.43 on Friday. The firm has a 50 day simple moving average of $98.88 and a two-hundred day simple moving average of $93.92. The stock has a market cap of $7.81 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Cracker Barrel Is at the Bottom of the Barrel: Time to Buy?
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Shopify Stock Has Analysts Buzzing About Big Gains
- Golden Cross Stocks: Pattern, Examples and Charts
- Roku Stock Gains New Buy Rating: Here’s Why Analysts Are Bullish
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.